BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform

News

Published: May 11, 2006

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform "

First Name*

Last Name*

Email Address*

Country*

Company Type*

Job Function*

Would you like to receive further email communication from Technology Networks?

Listen with

Speechify

0:00

Thank you. Listen to this article using the player above. ✖

Read time:

BioMag Corp., through its wholly owned subsidiary Biospectrum Technologies Inc., has announced that it has received its second patent from the U.S. Patent office on its High Throughput Screening - Magnetic Testing Platform (HTS-MTP) that is designed to produce both qualitative (yes/no) and quantitative (viral load) results from a single test.

Clayton Hardman, president and CEO of BioMag Corp., stated, "In addition to the HTS-MTP patent that was received from the U.S. Patent office in July of 2003, we have just received our second patent, further establishing our technology and enabling a broad spectrum of applications in which our product applies, in both medical testing and diagnostics."

"It is safe to say that our product is one of a kind in which can potentially revolutionize the diagnostic industry."

Drug Discovery

Drug Discovery

BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform